Tumor promoters and cell transformation.
Tumor promoters and cell transformation.
复制标题
DOI:
10.1016/0163-7258(84)90052-4
复制
发表时间:
1984
影响因子:
13.5
通讯作者:
Leila Diamond
中科院分区:
文献类型:
--
作者:
Leila Diamond
The concept that cancer is the end result of a multistage, multifactorial process has been reinforced by a wealth of epidemiological and experimental evidence that has appeared in the last decade or so. The factors involved may be chemical, physical or biological in nature and their sources may be endogenous or exogenous. Thus, one can consider that in humans one's entire lifestyle plays a part in the evolution of neoplastic disease, as Higginson (1983) has discussed. Perhaps the best example of the multistage, multifactorial nature of cancer in humans is the interaction of asbestos and cigarette smoking in the etiology of lung cancer, with the combined factors increasing the risk almost 900-fold compared to that in nonsmoking, nonasbestos workers (Selikoff and Hammond, 1975). The virologist, Peyton Rous, was one of the first to question whether" carcinogenic agents act in other ways besides bringing on neoplastic changes". He asked whether some may act in two ways: first, changing normal cells into neoplastic cells and, second, encouragingthe multiplication of the latter. In a 1944 publication that was the first to use the terms initiation and promotion in the context of tumor development, Friedewald and Rous presented a superb analysis and discussion of the separate and different effects involved in carcinogenesis. They demonstrated that latent tumor cells initiated in rabbit skin by one treatment could be forced or promoted to reveal themselves by subsequent treatment of the skin with agents which did not themselves initiate neoplastic change. Subsequently, the terms' initiation'and'promotion'have been defined by the protocol for two-stage carcinogenesis in mouse skin developed by Mottram (1944), Berenblum and Shubik (1947, 1949), and Berenblum (1954). In this now classic model system, a low, subcarcinogenic dose of a carcinogen (the initiator) is applied to the skin and this is followed by frequent, repeated applications of a promoter. Eventually papillomas develop and, if the promoter treatment is continued, some carcinomas develop. The initiating action by the carcinogen is irreversible, whereas the effect of the promoter, which is not